Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
38.45
-0.20 (-0.52%)
May 29, 2026, 1:49 PM CST
TPEX:7427 Market Cap
TPEX:7427 has a market cap or net worth of 1.64 billion as of May 29, 2026. Its market cap has decreased by -1.51% in one year.
Market Cap
1.64B
Enterprise Value
1.20B
Revenue
1.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
38.45
Market Cap Chart
Since July 8, 2021, TPEX:7427's market cap has increased from 1.48B to 1.64B, an increase of 10.90%. That is a compound annual growth rate of 2.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 1.64B | 19.31% |
| Dec 31, 2025 | 1.37B | -7.37% |
| Dec 31, 2024 | 1.48B | -42.09% |
| Dec 29, 2023 | 2.56B | 40.55% |
| Dec 30, 2022 | 1.82B | 94.83% |
| Dec 30, 2021 | 935.73M | -36.72% |
| Jul 8, 2021 | 1.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G&E Herbal Biotechnology | 2.02B |
| Gwo Xi Stem Cell Applied Technology Co. , | 1.98B |
| Greenyn Biotechnology | 1.81B |
| Synbio Tech | 1.72B |
| TaiRx | 1.68B |
| Anti-Microbial Savior BioteQ | 1.66B |
| Advagene Biopharma | 1.53B |
| Bio Preventive Medicine | 1.49B |